Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
出版年份 2017 全文链接
标题
Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
作者
关键词
-
出版物
Cell Death & Disease
Volume 8, Issue 2, Pages e2612-e2612
出版商
Springer Nature
发表日期
2017-02-09
DOI
10.1038/cddis.2017.38
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Review article: the epidemiology and prevention of gastric cancer
- (2014) K. M. Fock ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
- (2014) Song Chian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
- (2014) Johanna C. Bendell et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3
- (2014) Mon-Yuan Yang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis
- (2014) Yen-Chuan Ou et al. LIFE SCIENCES
- The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
- (2014) P. Wang et al. SCIENCE
- Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway
- (2013) Yun-yi Liu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SHP-1 in Cell-Cycle Regulation
- (2012) Pilar Lopez-Ruiz et al. Anti-Cancer Agents in Medicinal Chemistry
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop
- (2011) Zanobia A Syed et al. BMC CANCER
- Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells
- (2011) Shuling Huang et al. CANCER LETTERS
- STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
- (2011) R. B. Corcoran et al. CANCER RESEARCH
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms
- (2011) Prema S. Rao et al. INTERNATIONAL JOURNAL OF CANCER
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
- (2010) Chye-Sun Ong et al. CANCER LETTERS
- Luteolin Inhibits Protein Kinase C and c-Src Activities and UVB-Induced Skin Cancer
- (2010) S. Byun et al. CANCER RESEARCH
- The reactive oxygen species-Src-Stat3 pathway provokes negative feedback inhibition of apoptosis induced by high-fluence low-power laser irradiation
- (2010) Xuegang Sun et al. FEBS Journal
- Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1–5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia
- (2009) Ming-Chih Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1
- (2009) Ajaikumar B. Kunnumakkara et al. MOLECULAR CANCER RESEARCH
- STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
- (2009) Maureen M. Sherry et al. STEM CELLS
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression
- (2008) E. C. Brantley et al. CLINICAL CANCER RESEARCH
- Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line
- (2008) Bin Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- SOCS regulation of the JAK/STAT signalling pathway
- (2008) Ben A. Croker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search